Biblio
Dysfunctional polycomb transcriptional repression contributes to Lamin A/C dependent muscular dystrophy. J Clin Invest. 2020.
HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients. Trends Mol Med. 2024.
. HDAC inhibitors as pharmacological treatment for Duchenne muscular dystrophy: a discovery journey from bench to patients: (Trends in Molecular Medicine, 30:3 p:278-294, 2024). Trends Mol Med. 2024.
. Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy. Epigenomics. 2014;6(5):547-560.
.